LatAm-FINGERS 2026 Results: What Multidomain Dementia Risk Programs Can Teach Us

Learn what the trial's cognitive gains, cultural adaptations, and limits mean when assessing dementia-risk programs.

Learn what the trial's cognitive gains, cultural adaptations, and limits mean when assessing dementia-risk programs.

Learn what the AAIC 2026 p-tau217 results can predict, where the 10-year estimate falls short, and what to do now.

Learn what Tauklarify results can—and cannot—tell families during an Alzheimer evaluation.

Learn who qualifies, what PrecivityAD2 measures, how to read its results, and why clinical follow-up remains essential.

Learn who qualifies, which PrecivityAD2 version is available, and what its reported accuracy figures actually mean.

Build a clear, objective behavior timeline that helps clinicians assess patterns, triggers, daily effects, and possible causes.

Learn how to adapt beanbag toss for later-stage dementia and recognize when to continue, simplify, or stop.

Learn which documents to review, how capacity affects timing, and why guardianship is not automatic.

Learn how state hospice benefits, dementia eligibility, treatment waivers, and HCBS programs affect Medicaid coverage.

Learn which paranoia changes require emergency help, a prompt clinician call, or investigation for another cause.
HelpDementia.com
Dementia, Alzheimer's, Caregiving & Healthy Aging Guidance
© 2026 HelpDementia.com. All rights reserved.
Educational information only. It is not medical advice and does not replace care from a qualified clinician.